ZFP-TFs gene regulation technology designed by Sangamo therapeutics could repressed allele specific gene without affecting the normal allele.

Sangamo therapeutics on July 1 announced publication of a manuscript in Nature Medicine on the activity of allele-specific Zinc Finger Proteins (ZFP-TFs) in models of Huntington’s Disease. The data which was published online on July 1 will appear in the July 2019 issue of Nature Medicine.

Scientists from Sangamo and its collaborators from CHDI foundation have used Zinc Finger Proteins Transcriptions Factors (ZFP-TFs) to selectively targets mutant allele of the Huntington gene (HTT) and repress its expression 99% while retaining 86% of the normal allele.

Huntington is a fatal, progressive, neurodegenerative disorder caused by a dominant mutation involving the expansion of CAG trinucleotide repeat in exon 1 of the HTT gene. Fully penetrant disease alleles of mutant HTT have more than 39 CAG repeats, but most HD patients have one healthy wild-type copy of HTT with less than 22 CAG repeats. Sangamo scientist has developed ZFP-TFs which could bind only to the mutant allele avoiding the normal wild type and repressed its expression. Data from preclinical in vivo studies using different HD mouse models demonstrated improvements in a range of molecular, histopathological, electrophysiological, and other functional endpoints following treatment with Sangamo’s ZFP-TFs.

Finally, extensive in vivo tolerability assessments showed no evidence of a neuroinflammatory response or changes in behavior or locomotor function in mice treated with ZFP-TFs out to 15 months of age.

Sangamo's zinc finger protein transcription factor (ZFP-TFs) gene regulation technology:

IT is designed to either selectively repress (down-regulate) or activate (up-regulate) the expression of a specific gene or gene allele. Sangamo has a collaboration with Pfizer, deploying the ZFP-TF gene regulation approach to repress the expression of the mutated C9ORF72 gene allele linked to genetic forms of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Sangamo is also developing ZFP-TFs to down-regulate the expression of tau, a protein associated with Alzheimer's disease and other tauopathies.

About Huntington Disease:

Huntington’s disease (HD) is an inherited neurodegenerative disease that typically presents in adults aged between 30 and 50. HD is caused by a mutation in one of the alleles of the huntingtin gene (HTT), leaving only one functional or healthy copy of HTT in the cell. The mutated HTT produces the mutant HTT protein, leading to profound neuronal loss and progressive deterioration of motor, psychiatric, and cognitive abilities. There are currently no disease-modifying therapies available for HD.

Reference: Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington's disease. July Nature Medicine.

https://doi.org/10.1038/s41591-019-0478-3

Comments

Our top Stories

Scientist who developed India’s first indigenous vaccine dies at the age of 72.

Dr. M.K. Bhan addressing a Press Conference to apprise on the two significant R&D results emanating from DBT support, in New Delhi on May 31, 2012. The scientist who developed India’s first indigenous vaccine dies at 72. He was born in 1947, the year when India got independence and he passes away on 26th January, when India was celebrating its 71st Republic day. He was destined to be part of the country’s history. Maharaj Kishan Bhan is an Indian pediatrician and clinical scientist who developed the vaccine for rotavirus, the first indigenous vaccine produced in the country. He was born on 9th November 1947. He completed his MBBS degree from AFMC, Pune and M.D. Degree from Post Graduate Institute of Medical Education and Research, Chandigarh. As a faculty in AIIMS, Delhi he worked extensively on childhood diarrhea and nutrition. Childhood diarrhea is ...

Biodegradable burial pod turns your body into a tree.

Bretzel and Citelli with Capsula Mundi Model. Whenever a person dies, it is a burden for the family emotionally and financially. We spend thousands of dollars in funerals paying for the casket, flowers, and monuments. Environmentally, those caskets and monuments left behind an enormous carbon footprint. Recently, many people have begun to embrace the idea of green burials. People are environmentally more aware and there is a shift from cremation and the use of wood, the synthetic cushioning and the metals generally used in traditional coffins to green burial. Green burial is a method of burying the body in a wooden coffin without a concrete burial vault. The body along with the wooden coffin is degraded easily by the bacteria in the soil. This type of burial allows the graveyard to return to nature. Nearly 54 percent of Americans are considering green burial and 74 percent of cemeteries are reporting an increased demand for g...

Vaginal Microbiome Transplantation (VMT) shows promises against Bacterial Vaginosis.

What is Bacterial vaginosis? Normally, Lactobacillus species dominated the microbiome community of human Vagina. Bacterial vaginosis is a vaginal inflammation. It occurs when there is disbalance in the bacterial community i.e. when anaerobes dominate the microbiome instead of Lactobacillus species. Symptoms of BV: Bacterial vaginosis (BV) is prevalent in women of reproductive age affecting from one-fourth to one-third of women. BV may be associated with the risk of upper genital tract infection, complications of pregnancy and susceptibility to sexually transmitted infections (STDs). The study: In this study, five patients suffering from Bacterial vaginosis were recruited . A healthy vaginal fluid for transplantation was collected from the donors . They were then transferred to the patients suffering from BV. All the patients were monitored...

Researchers from USA and Germany developed stem cells that could evade immune attack.

Researchers from the USA in collaboration with some German scientists have developed stem cells that can evade immune attack of the host. They used CRISPR-Cas9 technology to develop the cells. MHC complex defines whether the cells are your own or foreign. During organ transplantation, MHC of the donor and the recipient should be matched. If there is a mismatch between the two individuals in their MHC, the immune cells of the recipient considers the transplanted organ as foreign and will be destroyed by immune cells. No two individuals have identical MHC complexes. Normally foreign cells are attacked by immune cells. This is the main reason for the difficulty in transplantation. Using CRISPR, the researcher has deleted the genes that code for MHC complex and as a result, there is no more MHC in the cells. Since there is no more MHC, they are not recognized as foreign and are accepted as their own. One problem is that those cells that have no MHC are the target of another cell...

Science Stories

Search This Blog